Anesthesia

Neuroleptic malignant syndrome

Neuroleptic malignant syndrome (NMS) is a clinical syndrome consisting of four primary features: rigidity, altered mental status, hyperthermia, and autonomic instability. It occurs in the setting of the use of dopamine-blocking agents or the withdrawal of dopamine-enhancing medications. Neuroleptic malignant syndrome Epidemiology Incidence of Neuroleptic malignant syndrome is estimated at 0.1% to 2%. There is

Neuroleptic malignant syndrome Read More »

Enflurane metabolism

Enflurane metabolism is briefly discussed. About 80-90% of enflurane is eliminated in expired air, up to 5% is metabolized by hepatic cytochrome P450 (2E1) to difluoromethoxy difluoroacetic acid and free fluoride. Carbon monoxide may be produced in the presence of dry soda lime or baralyme, at higher temperatures and higher anaesthetic concentrations. Also while studying

Enflurane metabolism Read More »

Scroll to Top